Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical TrialPRNewsWire • 08/07/23
Merck Stock Today: Why A Bear Call Spread Places $111 In Your Pocket TodayInvestors Business Daily • 08/04/23
U.S. FDA Approves Merck's ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and OlderBusiness Wire • 08/03/23
Merck Beats Quarterly Estimates, Lifts Outlook on Sales of Cancer Drug, HPV ShotInvestopedia • 08/01/23
Merck's Keytruda and Gardasil outperform expectations, boosting annual revenue forecastProactive Investors • 08/01/23
Merck posts narrower-than-expected loss as sales of top drugs beat Street estimatesReuters • 08/01/23
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus dealCNBC • 08/01/23